Furthermore, loss of BRCA1 in human ovarian cancer cells suppresses nuclear R-loop formation, resulting in accumulation of RNA-DNA hybrids in the cytoplasm (65) which have the potential to activate RIGI (64). The gene discussed is RIGI; the disease is ovarian carcinoma.